| Name | Title | Contact Details |
|---|
YMCA of Greater Brandywine is an association of eight YMCAs that offer life-changing programs for children, families and adults throughout Chester County, Pennsylvania.
Health Systems International is focused on healthcare affordability for our clients. Our goal is to ensure each interaction is paid at the most affordable amount for all involved. We do this through a set of Payment Integrity Solutions built on our data analytics, cloud-based, multi sided business platform and expertise in Provider and Network Data Management. Our solution set is designed to improve efficiencies, reduce cost, and provide insight though a unique set of prevention, prepayment and post payment solutions. Our company has a rich history in providing cost savings to multiple markets across the healthcare eco-system. Regardless of your specific market segment, be it a Payor, Health plan, TPA, P&C Carrier, Workers’ Compensation Administrator, PBM, HIE or ACO, you want to ensure the reimbursements paid by you and your members are accurate, appropriate, and at the most affordable rate. That is our focus! We bring decades of expertise, a commitment to information and analytics, and most importantly a culture that is dedicated and aligned to creating value for our customers and partners alike.
Our 50-minute Indoor Cycling class is a complete immersion into a high-intensity environment of energy and exercise. Our workouts are perfectly tailored to cutting edge playlists, and designed to be a retreat from everyday life. Each ride, physically and mentally stimulating, will challenge you to new heights.
Buffalo Neurosurgery Group is one of the leading providers in Healthcare, Pharmaceuticals, and Biotech. It is based in Buffalo, NY. To find more information about Buffalo Neurosurgery Group, please visit www.buffaloneuro.com
ProKidney, a pioneer in the treatment of chronic kidney disease (CKD) through innovations in cellular therapy, was founded in 2015 after a decade of research. ProKidney`s lead product candidate, REACT® (Renal Autologous Cell Therapy), is a first-of-its-kind, patented disease-modifying autologous cellular therapy with the potential to not only slow and stabilize the progression of CKD, but in some cases drive meaningful improvement in kidney function. REACT® has received Regenerative Medicine Advanced Therapy (RMAT) designation, as well as FDA and EMA guidance, supporting an immediate start to a global registrational program, which launched in the United States on schedule in January 2022. On January 18, 2022, ProKidney announced that it would become a publicly traded company via a business combination with Social Capital Suvretta Holdings Corp. III